Analytical chemistry continues to advance as sophisticated instrumentation, artificial intelligence (AI), and emerging analytical workflows provide deeper insight into complex biological systems. From high-content imaging and proteomics to biomarker discovery and therapeutic quality control, these technologies are enabling faster, more sensitive, and increasingly data-driven analysis.
In this Analytical Chemistry Industry Focus eBook, sponsored by Molecular Devices UK, we showcase the technologies and research developments shaping modern analytical science. The featured articles explore AI-powered image analysis, high-content imaging, mass spectrometry, proteomics, protein biology, and innovative approaches for assessing next-generation therapeutics.
What’s inside the Analytical Chemistry eBook?
This edition examines how AI and advanced imaging are improving phenotypic profiling, label-free cellular analysis, and compound toxicity assessment. It also explores the evolving role of mass spectrometry in clinical proteomics and biomarker development, including advances that are enabling greater proteome coverage and deeper molecular insight.
Beyond these areas, the eBook highlights emerging approaches for understanding protein structure and cellular quality control, alongside new analytical techniques designed to support the integrity and reliability of mRNA therapeutics.
Designed for those working in analytical chemistry, proteomics, drug discovery, biotechnology, and life science research, this eBook provides a snapshot of the technologies and discoveries driving more precise and multidimensional biological analysis.
Highlights from this eBook include:
- Accelerate phenotypic profiling with AI image analysis
- AI label-free detection with IN Carta image analysis
- High-content imaging improves compound toxicity assessment
- Why clinical proteomics faces a mass spectrometry vs. high-throughput profiling dilemma
- Next-Generation Mass Spectrometry Reveals How DIA Deepens Proteome Coverage
- Advancements in Mass Spectrometry for Clinical Biomarkers
- Scientists Uncover How “Sorting Hubs” Clear Damaged Proteins From Cells
- Protein Shape Changes Come Into Focus With LiP-MS and 3D Proteomics
- New laser technique ensures integrity of mRNA therapeutics
About Molecular Devices UK Ltd
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.